In the paper, an analysis of acute postoperative hemorrhages in 30 patients after operations on the abdomen is presented. In these patients 42 relaparatomies have been performed with lethal issues in 16.7%. The causes of this complication are analysed, and recommendations how to prevent them are given.
Download full-text PDF |
Source |
---|
HPB (Oxford)
November 2024
Department of Surgical Oncology, I.R.C.C.S Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124, Bari, Italy.
Background: Consensus on the nomenclature and indications for reoperation for post-operative pancreatic fistula (POPF) after pancreatoduodenectomy (PD) is lacking. This study explores the available literature to classify the different types of reoperations and report outcomes.
Methods: A systematic literature search was performed, including articles from 2010 to 2024 reporting reoperations for POPF after PD.
Ulus Travma Acil Cerrahi Derg
October 2024
Department of General Surgery, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul-Türkiye.
Int J Surg Case Rep
June 2024
Komfo Anokye Teaching Hospital, Directorate of Surgery, P.O. Box 1934, Kumasi, Ghana.
Introduction: Congenital causes of duodenal obstruction can be grouped into intrinsic and extrinsic causes. The degree of obstruction caused by such etiologies determines the severity and timing of symptom presentation. Early neonatal diagnosis is common in patients with etiologies that present with high degrees of obstruction such as atresia whereas etiologies that cause lesser degrees of obstruction such as malrotation and duodenal stenosis can go undiagnosed into adulthood.
View Article and Find Full Text PDFSurg Infect (Larchmt)
April 2024
Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky, USA.
Appropriate antimicrobial therapy for the management of intra-abdominal infection (IAI) continues to evolve based on available literature. The Study to Optimize Peritoneal Infection Therapy (STOP-IT) trial provided evidence to support four days of antibiotic agents in IAI post-source control but excluded patients with a planned re-laparotomy. This study aimed to determine the short- and long-term recurrent infection risk in this population.
View Article and Find Full Text PDFPancreatology
December 2023
Department of General and Pancreatic Surgery, The Pancreas Institute, University of Verona Hospital Trust, Verona, Italy.
Background: While the use of protease inhibitor gabexate mesylate (GM) is still controversial in acute pancreatitis, it has never been tested for postpancreatectomy acute pancreatitis (PPAP). This study aims to assess the impact of GM on postoperative serum hyperamylasaemia (POH) or PPAP after pancreatoduodenectomy (PD).
Methods: Consecutive patients developing POH after PD between 2016 and 2021 were included.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!